|
EPS15L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.496420E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.601000E-01 |
| Normal-vs-Stage2 |
4.151000E-01 |
| Normal-vs-Stage3 |
2.354000E-02 |
| Normal-vs-Stage4 |
9.668000E-02 |
| Stage1-vs-Stage2 |
4.943000E-01 |
| Stage1-vs-Stage3 |
3.154200E-02 |
| Stage1-vs-Stage4 |
2.783700E-02 |
| Stage2-vs-Stage3 |
1.124450E-01 |
| Stage2-vs-Stage4 |
2.282800E-01 |
| Stage3-vs-Stage4 |
7.688600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.197700E-02 |
| Normal-vs-AfricanAmerican |
4.356400E-01 |
| Normal-vs-Asian |
2.098400E-01 |
| Caucasian-vs-AfricanAmerican |
4.870800E-01 |
| Caucasian-vs-Asian |
8.595700E-02 |
| AfricanAmerican-vs-Asian |
2.612200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.044170E-01 |
| Normal-vs-Female |
4.084800E-03 |
| Male-vs-Female |
1.150820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.666550E-01 |
| Normal-vs-Extreme_Weight |
4.103400E-01 |
| Normal-vs-Obese |
4.895500E-02 |
| Normal-vs-Extreme_Obese |
6.784600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.146200E-01 |
| Normal_Weight-vs-Obese |
4.720600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.726400E-01 |
| Extreme_Weight-vs-Obese |
1.810200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.507000E-01 |
| Obese-vs-Extreme_Obese |
6.372000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.941930E-02 |
| Normal-vs-Age(41-60Yrs) |
4.212400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.347000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.163200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.585640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.473510E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.295800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.886400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.446000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.454000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.468200E-01 |
| Normal-VS-Type2 PRCC |
6.175500E-03 |
| Normal-VS-KIRP CIMP |
7.685800E-02 |
| Normal-VS-Unclassified PRCC |
8.187700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.024480E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.672100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.310850E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.401400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.589400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.241400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.158800E-01 |
| Normal-vs-N1 |
6.437400E-03 |
| Normal-vs-N2 |
4.263600E-01 |
| N0-vs-N1 |
1.816390E-01 |
| N0-vs-N2 |
8.202800E-01 |
| N1-vs-N2 |
6.429400E-01 |
|
|
